共 50 条
Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum
被引:0
|作者:
Becker, Sarah L.
[1
]
Rios-Duarte, Jorge A.
[2
]
Morrison, Georgia Mae
[1
]
Xia, Eric
[3
,4
]
Mostaghimi, Arash
[3
]
Himed, Sonia
[5
]
Kaffenberger, Benjamin H.
[5
]
Zhang, Donglin
[6
]
Shields, Bridget E.
[6
]
Cogen, Anna L.
[7
]
Ortega-Loayza, Alex G.
[1
]
机构:
[1] Oregon Hlth & Sci Univ, Dept Dermatol, 3303 S Bond Ave Bldg 1,16th Floor, Portland, OR 97239 USA
[2] Univ Los Andes, Sch Med, Bogota, DC, Colombia
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA USA
[4] Boston Univ, Sch Med, Boston, MA USA
[5] Ohio State Univ, Dept Dermatol, Columbus, OH USA
[6] Univ Wisconsin, Madison, WI USA
[7] Univ Washington, Seattle, WA USA
关键词:
Peristomal pyoderma gangrenosum;
Irritable bowel disease;
Perioperative outcomes;
FEATURES;
RISK;
D O I:
10.1007/s00403-024-02826-3
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
Peristomal pyoderma gangrenosum is an uncommon subtype of pyoderma gangrenosum mainly affecting stoma sites of patients with inflammatory bowel disease. While surgical treatments are often used to assist healing, little is known about the relationship between surgical interventions and the rate of recurrence of peristomal pyoderma gangrenosum. The aim of this study was to identify patient and clinical factors associated with peristomal pyoderma gangrenosum recurrence following surgical intervention. A multi-institutional retrospective case series and literature review was conducted to evaluate patient characteristics and perioperative treatment. Patients of any age with peristomal pyoderma gangrenosum undergoing surgical operations related to their pyoderma gangrenosum or due to another comorbidity were included. Descriptive statistics were used to characterize demographic information. Associations were evaluated using Wilcoxon's rank-sum test for continuous variables and Fisher's exact test for categorical data. Thirty-seven cases were included, 78.3% of which had a history of inflammatory bowel disease. Overall, 13 (35.1%) cases experienced recurrence at 30 days. There was no significant association identified between patient demographics, stoma location, surgical intervention, or perioperative treatment with rate of recurrence at 30 days post-operation. While no clinical risk factors or treatments were associated with recurrence, our work underscores the importance of a multidisciplinary approach to this disease to address gastrointestinal, dermatologic, and surgical components of treatment.
引用
收藏
页数:5
相关论文